Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-019192
Filing Date
2020-07-15
Accepted
2020-07-15 17:31:21
Documents
2
Period of Report
2020-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7960
2 EX-24 DOCUMENT attachment1.htm EX-24 3810
  Complete submission text file 0000899243-20-019192.txt   13142
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Lyon Joseph Douglas (Reporting) CIK: 0001817838 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 201030243